e-learning
resources
Amsterdam 2011
Wednesday, 28.09.2011
Role of the biomarkers in airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Metabolomic analysis of exhaled breath condensate in diagnostics of obstructive airway diseases
T. N. Anokhina, E. K. Anaev, A. A. Rodionov, A. I. Revelsky, I. A. Revelsky, V. B. Kudriavtsev, A. G. Chuchalin (Moscow, Russian Federation)
Source:
Annual Congress 2011 - Role of the biomarkers in airway diseases
Session:
Role of the biomarkers in airway diseases
Session type:
Poster Discussion
Number:
4791
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. N. Anokhina, E. K. Anaev, A. A. Rodionov, A. I. Revelsky, I. A. Revelsky, V. B. Kudriavtsev, A. G. Chuchalin (Moscow, Russian Federation). Metabolomic analysis of exhaled breath condensate in diagnostics of obstructive airway diseases. Eur Respir J 2011; 38: Suppl. 55, 4791
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Diagnosis of lung diseases based on proteomic analysis of exhaled breath condensate
Source: International Congress 2017 – Clinical problems in lung diseases
Year: 2017
Exhaled breath condensate biomarkers in COPD
Source: Eur Respir J 2008; 32: 472-486
Year: 2008
Markers of airway diseases in exhaled breath condensate and their clinical value
Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases
Year: 2013
Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation
Year: 2008
Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 25: 269-274
Year: 2005
Structures of an exhaled breath condensate in lung diseases
Source: Eur Respir J 2005; 26: Suppl. 49, 525s
Year: 2005
Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008
Changes in exhaled breath condensate in asthma and COPD: A full analysis of mass-spectra
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010
Exhaled breath condensate for evaluation of inflammation in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 35s
Year: 2006
Correlation between lung function and exhaled breath condensate biomarkers of inflammation in pulmonary diseases
Source: Annual Congress 2009 - Lung function in adults and children
Year: 2009
Inflammatory markers in exhaled breath condensate in bronchiectasis
Source: Eur Respir J 2004; 24: Suppl. 48, 707s
Year: 2004
Inflammatory markers in exhaled breath condensate of two COPD phenotypes
Source: Eur Respir J 2005; 26: Suppl. 49, 260s
Year: 2005
Analysis of semi-volatile organic compounds in exhaled breath condensate of patients with obstructive lung diseases
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Metabonomics applied to exhaled breath condensate in childhood asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 123s
Year: 2006
Sensors for detecting pulmonary diseases from exhaled breath
Source: Eur Respir Rev, 28 (152) 190011; 10.1183/16000617.0011-2019
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept